Genentech
Top stories
Latest
- Genentech Presents New Data at EURETINA, Highlighting Vabysmo’s Real-World Effectiveness and Safety Across Major Retinal Conditionstimesargus.com · 2026-10-01 06:01 UTC · story
- Court: 'Drug request through Kim Seung-won is clear'... Genentech founder sentenced to 4 years in prison and 4 years of probationdonga.com · 2026-09-30 19:30 UTC · story

- Genentech: FDA Grants Priority Review To Fenebrutinib NDA For Relapsing And Primary Progressive MSrttnews.com · 2026-09-30 05:37 UTC · story
- Genentech’s Fenebrutinib Is the First BTK Inhibitor to Receive U.S. FDA Filing Acceptance in Both Relapsing and Primary Progressive Multiple Sclerosistimesargus.com · 2026-09-30 05:00 UTC · story
- Hanmi Pharmaceuticals, rights to export cancer drug technology from 10 years ago revoked... contract with Genentech terminatedetoday.co.kr · 2026-09-29 12:19 UTC · story
- Hanmi Pharmaceuticals, Genentech 'Belvarafenib' technology transfer contract terminatedmt.co.kr · 2026-09-29 08:58 UTC · 1 more reports

- Korean-American Pharmaceuticals cancels 'Belbarafenib' L/O... Returning rights to Genentechcdn.medipana.com · 2026-09-29 08:58 UTC · story
- Genentech Breaks Ground on $750 Million Manufacturing Expansion in Hillsboro, Oregontimesargus.com · 2026-09-28 22:02 UTC · story